Antibody Purification Kits Search Results


99
Qiagen rneasy micro kit
Rneasy Micro Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pm30859691-101-15-18?v=Qiagen
Average 99 stars, based on 1 article reviews
rneasy micro kit - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
Qiagen rneasy mini kit
Key resources table.
Rneasy Mini Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pmc10181927-146-2-7?v=Qiagen
Average 99 stars, based on 1 article reviews
rneasy mini kit - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

90
Antagen Pharmaceuticals mouse immunoglobulin isotyping kit
Key resources table.
Mouse Immunoglobulin Isotyping Kit, supplied by Antagen Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pmc07599229-324-9-13?v=Antagen+Pharmaceuticals
Average 90 stars, based on 1 article reviews
mouse immunoglobulin isotyping kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

97
Miltenyi Biotec magnetic beads
Key resources table.
Magnetic Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/bio_rxiv__64898__2026__03__13__711488-164-11-13?v=Miltenyi+Biotec
Average 97 stars, based on 1 article reviews
magnetic beads - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

93
fluidigm maxpar x8 antibody labeling kit
Representative surface staining panel design—Mouse immune panel
Maxpar X8 Antibody Labeling Kit, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pmc09794973-111-0-8?v=fluidigm
Average 93 stars, based on 1 article reviews
maxpar x8 antibody labeling kit - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

99
Thermo Fisher micro bca tm protein assay kit
KEY RESOURCES TABLE
Micro Bca Tm Protein Assay Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pmc11290456-50-0-7?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
micro bca tm protein assay kit - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
Abcam goat anti ahr
a, Left: representative immunofluorescence images of tissue array from human gliomas stained <t>for</t> <t>TMEM119</t> (red), CD68 (green), CD39 (cyan) and nuclei (blue). Scale bars, 20 μm. Right: quantification of the total number of CD39+ CD68+ TMEM119Neg cells in 33 glioma samples classified as grade 1 (n = 2), grade 2 (n = 14), grade 3 (n = 8) or grade 4 (n = 9). Kruskal–Wallis test. b, Flow cytometry analysis of CD39 expression in peripheral infiltrated macrophages in TAMs (LinNeg CD11b+ CD45Hi) gated from WT and AHRLysM mice 17 days after GL261 cell implantation (n = 3 independent mice). Representative histogram shown on the left and quantification analysis on the right. c, <t>AHR</t> recruitment to the Entpd1 promoter as assessed by ChIP in KYN- or TCM-stimulated BMDMs in the presence or absence of an AHR inhibitor (n = 3 technical replicates). d, Relative expression of luciferase activity in HEK293 cells transfected with a luciferase reporter driven by the ENTPD1 promoter alone, or with a construct coding for AHR, and stimulated TCM for 24 h. RPMI condition was the reference sample (n = 3 technical replicates). e, Representative images from intracranial tumors in WT and CD39LysM mice 21 days after GL261-luciferase cell implantation (n = 4 independent mice). f, Survival curve analysis of WT and CD39LysM mice implanted intracranially with GL261-luciferase cells (n = 8 independent mice). g,h, Total number of TILs (CD3+ CD8+) (g) and percentage of IFN-γ+ cells in TILs (h) gated from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (n = 3 independent mice). i–k, Nanostring analysis of sorted CD8+ TILs from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (pool of 5 mice per group). Heatmap of gene expression for all genes (i) and of T cell dysfunction-related genes (j). k, Ratio of the expression of genes related to CD8+ T cell dysfunction in WT and CD39LysM mice. l–n, Naive CD8+ T cells purified using beads activated with anti-CD3 and anti-CD28 monoclonal antibodies in the presence or absence of adenosine for 48 h (n = 3 technical replicates for all analyses). Expression levels of T cell effector and dysfunction genes were analyzed by qPCR (l), frequency of IFN-γ+ cells in CD8+ T cells by FACS (m) and cytokines production by ELISA (n). Data in b–h and l–n are representative of two independent experiments; similar results were obtained. Data in a–e, g, h, l–n are shown as mean ± s.e.m. P values were determined by two-sided Student’s t-tests (b, e, g, h, l–n) or one-way ANOVA (a, c and d), and survival analysis was performed using a Kaplan–Meier plot using a log-rank (Mantel–Cox) test (f).
Goat Anti Ahr, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pmc08052632-739-36-41?v=Abcam
Average 99 stars, based on 1 article reviews
goat anti ahr - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

95
Bio X Cell anti panmhc i antibody w6 32
a, Left: representative immunofluorescence images of tissue array from human gliomas stained <t>for</t> <t>TMEM119</t> (red), CD68 (green), CD39 (cyan) and nuclei (blue). Scale bars, 20 μm. Right: quantification of the total number of CD39+ CD68+ TMEM119Neg cells in 33 glioma samples classified as grade 1 (n = 2), grade 2 (n = 14), grade 3 (n = 8) or grade 4 (n = 9). Kruskal–Wallis test. b, Flow cytometry analysis of CD39 expression in peripheral infiltrated macrophages in TAMs (LinNeg CD11b+ CD45Hi) gated from WT and AHRLysM mice 17 days after GL261 cell implantation (n = 3 independent mice). Representative histogram shown on the left and quantification analysis on the right. c, <t>AHR</t> recruitment to the Entpd1 promoter as assessed by ChIP in KYN- or TCM-stimulated BMDMs in the presence or absence of an AHR inhibitor (n = 3 technical replicates). d, Relative expression of luciferase activity in HEK293 cells transfected with a luciferase reporter driven by the ENTPD1 promoter alone, or with a construct coding for AHR, and stimulated TCM for 24 h. RPMI condition was the reference sample (n = 3 technical replicates). e, Representative images from intracranial tumors in WT and CD39LysM mice 21 days after GL261-luciferase cell implantation (n = 4 independent mice). f, Survival curve analysis of WT and CD39LysM mice implanted intracranially with GL261-luciferase cells (n = 8 independent mice). g,h, Total number of TILs (CD3+ CD8+) (g) and percentage of IFN-γ+ cells in TILs (h) gated from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (n = 3 independent mice). i–k, Nanostring analysis of sorted CD8+ TILs from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (pool of 5 mice per group). Heatmap of gene expression for all genes (i) and of T cell dysfunction-related genes (j). k, Ratio of the expression of genes related to CD8+ T cell dysfunction in WT and CD39LysM mice. l–n, Naive CD8+ T cells purified using beads activated with anti-CD3 and anti-CD28 monoclonal antibodies in the presence or absence of adenosine for 48 h (n = 3 technical replicates for all analyses). Expression levels of T cell effector and dysfunction genes were analyzed by qPCR (l), frequency of IFN-γ+ cells in CD8+ T cells by FACS (m) and cytokines production by ELISA (n). Data in b–h and l–n are representative of two independent experiments; similar results were obtained. Data in a–e, g, h, l–n are shown as mean ± s.e.m. P values were determined by two-sided Student’s t-tests (b, e, g, h, l–n) or one-way ANOVA (a, c and d), and survival analysis was performed using a Kaplan–Meier plot using a log-rank (Mantel–Cox) test (f).
Anti Panmhc I Antibody W6 32, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pm33271120-340-7-13?v=Bio+X+Cell
Average 95 stars, based on 1 article reviews
anti panmhc i antibody w6 32 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

99
Abcam high sensitivity chip kit
a, Left: representative immunofluorescence images of tissue array from human gliomas stained <t>for</t> <t>TMEM119</t> (red), CD68 (green), CD39 (cyan) and nuclei (blue). Scale bars, 20 μm. Right: quantification of the total number of CD39+ CD68+ TMEM119Neg cells in 33 glioma samples classified as grade 1 (n = 2), grade 2 (n = 14), grade 3 (n = 8) or grade 4 (n = 9). Kruskal–Wallis test. b, Flow cytometry analysis of CD39 expression in peripheral infiltrated macrophages in TAMs (LinNeg CD11b+ CD45Hi) gated from WT and AHRLysM mice 17 days after GL261 cell implantation (n = 3 independent mice). Representative histogram shown on the left and quantification analysis on the right. c, <t>AHR</t> recruitment to the Entpd1 promoter as assessed by ChIP in KYN- or TCM-stimulated BMDMs in the presence or absence of an AHR inhibitor (n = 3 technical replicates). d, Relative expression of luciferase activity in HEK293 cells transfected with a luciferase reporter driven by the ENTPD1 promoter alone, or with a construct coding for AHR, and stimulated TCM for 24 h. RPMI condition was the reference sample (n = 3 technical replicates). e, Representative images from intracranial tumors in WT and CD39LysM mice 21 days after GL261-luciferase cell implantation (n = 4 independent mice). f, Survival curve analysis of WT and CD39LysM mice implanted intracranially with GL261-luciferase cells (n = 8 independent mice). g,h, Total number of TILs (CD3+ CD8+) (g) and percentage of IFN-γ+ cells in TILs (h) gated from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (n = 3 independent mice). i–k, Nanostring analysis of sorted CD8+ TILs from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (pool of 5 mice per group). Heatmap of gene expression for all genes (i) and of T cell dysfunction-related genes (j). k, Ratio of the expression of genes related to CD8+ T cell dysfunction in WT and CD39LysM mice. l–n, Naive CD8+ T cells purified using beads activated with anti-CD3 and anti-CD28 monoclonal antibodies in the presence or absence of adenosine for 48 h (n = 3 technical replicates for all analyses). Expression levels of T cell effector and dysfunction genes were analyzed by qPCR (l), frequency of IFN-γ+ cells in CD8+ T cells by FACS (m) and cytokines production by ELISA (n). Data in b–h and l–n are representative of two independent experiments; similar results were obtained. Data in a–e, g, h, l–n are shown as mean ± s.e.m. P values were determined by two-sided Student’s t-tests (b, e, g, h, l–n) or one-way ANOVA (a, c and d), and survival analysis was performed using a Kaplan–Meier plot using a log-rank (Mantel–Cox) test (f).
High Sensitivity Chip Kit, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pmc07007814-60-8-12?v=Abcam
Average 99 stars, based on 1 article reviews
high sensitivity chip kit - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

94
Chondrex Inc mouse anti ova ige antibody assay kit
Role of Bcl6-mediated MPT cell functions in NAT H 2 differentiation in an allergic murine model. [ (A) top] Mixture of purified KJ1-26 − MPT cells ( Bcl6 -WT or Bcl6 -KO) and KJ1-26 + WT naïve CD4 + T cells were transferred into BALB/c nu/nu mice intravenously (day 0). These mice were immunized with alum-conjugated <t>OVA</t> and then intratracheally challenged with OVA. [ (A) bottom] Absolute cell numbers of Neu, Eos, AM, and Lym in BALF, (B) hematoxylin and eosin-stained, formalin-fixed lung sections (magnification: 200×), and (C) T H 2 cytokine levels in the BALF of recipient mice 48 h after the last OVA challenge. (D) Relative Il4, Il5 , and Il13 expression mRNA in splenic KJ1-26 + T cells restimulated with anti-CD3 monoclonal antibodies 5 days after the last challenge. (E) OVA-specific <t>IgE</t> antibody titers in sera from each recipient of Bcl6 -WT NAT H 2 cells, plus MPT H 2 cells transferred from Bcl6 -TG, Bcl6 -WT, or Bcl6 -KO mice 2 days after the last challenge. All results are representative of four independent experiments with similar outcomes. Data are presented as the mean ± SEM ( n = 5–7). * P < 0.05, ** P < 0.01, comparison between two groups is indicated. AM, alveolar macrophages; BALF, bronchoalveolar lavage fluid; Bcl6, B-cell lymphoma 6; Eos, eosinophils; KJ + , KJ1-26-positive; KO, knockout; Lym, lymphocytes; MPT cell, memory phenotype CD4 + T cell; MPT H 2 cell, MPT cell-derived T H 2 cell; NAT H 2 cell; naïve CD4 + T cell-derived T H 2 cell; Neu, neutrophils; NS, not significant; OVA, ovalbumin; TG, transgenic; WT, wild-type.
Mouse Anti Ova Ige Antibody Assay Kit, supplied by Chondrex Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pmc05904433-50-7-13?v=Chondrex+Inc
Average 94 stars, based on 1 article reviews
mouse anti ova ige antibody assay kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Novus Biologicals human iga igg elisa kit
Circulating plasma antibody reactivity to oral commensals identified in pancreatic tumor lesions. Plasma diluent (1/300) from patients with histology verified pancreas tissues: IPMN with low grade dysplasia (LGD-IPMN), IPMN with high grade dysplasia or with invasive cancer (HGD-IPMN + Cancer), or benign tumors/non-IPMN (Control) was tested in duplicates in <t>ELISA</t> plates coated with indicated antigen in (A–F) (bacteria: 5 × 10E7 CFU/ml, peptide 10 μg/mL). The total plasma IgG level is shown in (G) . Internal control Mean OD absorbance values of duplicates are shown. Statistical analysis was performed using the Kolmogorov–Smirnov test, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Human Iga Igg Elisa Kit, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/pmc07484485-101-12-16?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
human iga igg elisa kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
Bethyl human iga elisa quantitation kit
Circulating plasma antibody reactivity to oral commensals identified in pancreatic tumor lesions. Plasma diluent (1/300) from patients with histology verified pancreas tissues: IPMN with low grade dysplasia (LGD-IPMN), IPMN with high grade dysplasia or with invasive cancer (HGD-IPMN + Cancer), or benign tumors/non-IPMN (Control) was tested in duplicates in <t>ELISA</t> plates coated with indicated antigen in (A–F) (bacteria: 5 × 10E7 CFU/ml, peptide 10 μg/mL). The total plasma IgG level is shown in (G) . Internal control Mean OD absorbance values of duplicates are shown. Statistical analysis was performed using the Kolmogorov–Smirnov test, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Human Iga Elisa Quantitation Kit, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Antibody+Purification+Kits/10__1128_slash_iai__69__5__2935___2942__2001-92-30-35?v=Bethyl
Average 93 stars, based on 1 article reviews
human iga elisa quantitation kit - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

Image Search Results


Key resources table.

Journal: Cell Death & Disease

Article Title: Obesity impairs cardiolipin-dependent mitophagy and therapeutic intercellular mitochondrial transfer ability of mesenchymal stem cells

doi: 10.1038/s41419-023-05810-3

Figure Lengend Snippet: Key resources table.

Article Snippet: 39 , RNeasy Mini Kit (250) , Qiagen , 74106.

Techniques: Recombinant, Control, Staining, Isolation, Enzyme-linked Immunosorbent Assay, Live Dead Assay, TUNEL Assay, ATP Assay, Protease Inhibitor, cDNA Synthesis, Saline, Purification

Representative surface staining panel design—Mouse immune panel

Journal: STAR Protocols

Article Title: CyTOF protocol for immune monitoring of solid tumors from mouse models

doi: 10.1016/j.xpro.2022.101949

Figure Lengend Snippet: Representative surface staining panel design—Mouse immune panel

Article Snippet: Maxpar® X8 Antibody Labeling Kit, 167Er—4 Rxn , Standard BioTools , 201167A.

Techniques: Staining, Marker

Journal: STAR Protocols

Article Title: CyTOF protocol for immune monitoring of solid tumors from mouse models

doi: 10.1016/j.xpro.2022.101949

Figure Lengend Snippet:

Article Snippet: Maxpar® X8 Antibody Labeling Kit, 167Er—4 Rxn , Standard BioTools , 201167A.

Techniques: Blocking Assay, Purification, Recombinant, Staining, Sterility, Antibody Labeling, Software, Transferring, Microscopy

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Pten regulates endocytic trafficking of cell adhesion and Wnt signaling molecules to pattern the retina

doi: 10.1016/j.celrep.2024.114005

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Micro BCA TM Protein Assay Kit , ThermoFisher Scientific , Cat# #23235 RRID: N/A.

Techniques: Control, Affinity Purification, Recombinant, Bicinchoninic Acid Protein Assay, Western Blot, Electron Microscopy, RNAscope, Multiplex Assay, Mass Spectrometry, Mutagenesis, Software, Microscopy

a, Left: representative immunofluorescence images of tissue array from human gliomas stained for TMEM119 (red), CD68 (green), CD39 (cyan) and nuclei (blue). Scale bars, 20 μm. Right: quantification of the total number of CD39+ CD68+ TMEM119Neg cells in 33 glioma samples classified as grade 1 (n = 2), grade 2 (n = 14), grade 3 (n = 8) or grade 4 (n = 9). Kruskal–Wallis test. b, Flow cytometry analysis of CD39 expression in peripheral infiltrated macrophages in TAMs (LinNeg CD11b+ CD45Hi) gated from WT and AHRLysM mice 17 days after GL261 cell implantation (n = 3 independent mice). Representative histogram shown on the left and quantification analysis on the right. c, AHR recruitment to the Entpd1 promoter as assessed by ChIP in KYN- or TCM-stimulated BMDMs in the presence or absence of an AHR inhibitor (n = 3 technical replicates). d, Relative expression of luciferase activity in HEK293 cells transfected with a luciferase reporter driven by the ENTPD1 promoter alone, or with a construct coding for AHR, and stimulated TCM for 24 h. RPMI condition was the reference sample (n = 3 technical replicates). e, Representative images from intracranial tumors in WT and CD39LysM mice 21 days after GL261-luciferase cell implantation (n = 4 independent mice). f, Survival curve analysis of WT and CD39LysM mice implanted intracranially with GL261-luciferase cells (n = 8 independent mice). g,h, Total number of TILs (CD3+ CD8+) (g) and percentage of IFN-γ+ cells in TILs (h) gated from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (n = 3 independent mice). i–k, Nanostring analysis of sorted CD8+ TILs from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (pool of 5 mice per group). Heatmap of gene expression for all genes (i) and of T cell dysfunction-related genes (j). k, Ratio of the expression of genes related to CD8+ T cell dysfunction in WT and CD39LysM mice. l–n, Naive CD8+ T cells purified using beads activated with anti-CD3 and anti-CD28 monoclonal antibodies in the presence or absence of adenosine for 48 h (n = 3 technical replicates for all analyses). Expression levels of T cell effector and dysfunction genes were analyzed by qPCR (l), frequency of IFN-γ+ cells in CD8+ T cells by FACS (m) and cytokines production by ELISA (n). Data in b–h and l–n are representative of two independent experiments; similar results were obtained. Data in a–e, g, h, l–n are shown as mean ± s.e.m. P values were determined by two-sided Student’s t-tests (b, e, g, h, l–n) or one-way ANOVA (a, c and d), and survival analysis was performed using a Kaplan–Meier plot using a log-rank (Mantel–Cox) test (f).

Journal: Nature neuroscience

Article Title: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39

doi: 10.1038/s41593-019-0370-y

Figure Lengend Snippet: a, Left: representative immunofluorescence images of tissue array from human gliomas stained for TMEM119 (red), CD68 (green), CD39 (cyan) and nuclei (blue). Scale bars, 20 μm. Right: quantification of the total number of CD39+ CD68+ TMEM119Neg cells in 33 glioma samples classified as grade 1 (n = 2), grade 2 (n = 14), grade 3 (n = 8) or grade 4 (n = 9). Kruskal–Wallis test. b, Flow cytometry analysis of CD39 expression in peripheral infiltrated macrophages in TAMs (LinNeg CD11b+ CD45Hi) gated from WT and AHRLysM mice 17 days after GL261 cell implantation (n = 3 independent mice). Representative histogram shown on the left and quantification analysis on the right. c, AHR recruitment to the Entpd1 promoter as assessed by ChIP in KYN- or TCM-stimulated BMDMs in the presence or absence of an AHR inhibitor (n = 3 technical replicates). d, Relative expression of luciferase activity in HEK293 cells transfected with a luciferase reporter driven by the ENTPD1 promoter alone, or with a construct coding for AHR, and stimulated TCM for 24 h. RPMI condition was the reference sample (n = 3 technical replicates). e, Representative images from intracranial tumors in WT and CD39LysM mice 21 days after GL261-luciferase cell implantation (n = 4 independent mice). f, Survival curve analysis of WT and CD39LysM mice implanted intracranially with GL261-luciferase cells (n = 8 independent mice). g,h, Total number of TILs (CD3+ CD8+) (g) and percentage of IFN-γ+ cells in TILs (h) gated from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (n = 3 independent mice). i–k, Nanostring analysis of sorted CD8+ TILs from WT and CD39LysM mice 15 days after GL261-luciferase cell implantation (pool of 5 mice per group). Heatmap of gene expression for all genes (i) and of T cell dysfunction-related genes (j). k, Ratio of the expression of genes related to CD8+ T cell dysfunction in WT and CD39LysM mice. l–n, Naive CD8+ T cells purified using beads activated with anti-CD3 and anti-CD28 monoclonal antibodies in the presence or absence of adenosine for 48 h (n = 3 technical replicates for all analyses). Expression levels of T cell effector and dysfunction genes were analyzed by qPCR (l), frequency of IFN-γ+ cells in CD8+ T cells by FACS (m) and cytokines production by ELISA (n). Data in b–h and l–n are representative of two independent experiments; similar results were obtained. Data in a–e, g, h, l–n are shown as mean ± s.e.m. P values were determined by two-sided Student’s t-tests (b, e, g, h, l–n) or one-way ANOVA (a, c and d), and survival analysis was performed using a Kaplan–Meier plot using a log-rank (Mantel–Cox) test (f).

Article Snippet: The following primary antibodies were used in this study: mouse anti-L-KYN (1:100; no. IS003 clone 3D4-F2, ImmuSmol); goat anti-CD14 (1:100; no. LS-B3012–50, LifeSpan Biosciences); rabbit anti-TMEM119 (1:500; no. ab185333, Abcam); mouse anti-CD39 (1:100; no. 328202, Biolegend); goat anti-AHR (1:100; no. ab186070, Abcam); mouse anti-AHR (1:100; no. ab2769, Abcam); mouse anti-CD68 (1:100; no. ab955, Abcam); rabbit anti-CD8 (0.175 μg ml −1 ; no. 790–4460, Ventana Labs); rabbit anti-CD4 (0.5 μg ml −1 ; no. 790–4423, Ventana Labs); and rat anti-CD3 (1.2 μg ml −1 ; no. MCA1477, Bio-Rad).

Techniques: Immunofluorescence, Staining, Flow Cytometry, Expressing, Luciferase, Activity Assay, Transfection, Construct, Purification, Enzyme-linked Immunosorbent Assay

Role of Bcl6-mediated MPT cell functions in NAT H 2 differentiation in an allergic murine model. [ (A) top] Mixture of purified KJ1-26 − MPT cells ( Bcl6 -WT or Bcl6 -KO) and KJ1-26 + WT naïve CD4 + T cells were transferred into BALB/c nu/nu mice intravenously (day 0). These mice were immunized with alum-conjugated OVA and then intratracheally challenged with OVA. [ (A) bottom] Absolute cell numbers of Neu, Eos, AM, and Lym in BALF, (B) hematoxylin and eosin-stained, formalin-fixed lung sections (magnification: 200×), and (C) T H 2 cytokine levels in the BALF of recipient mice 48 h after the last OVA challenge. (D) Relative Il4, Il5 , and Il13 expression mRNA in splenic KJ1-26 + T cells restimulated with anti-CD3 monoclonal antibodies 5 days after the last challenge. (E) OVA-specific IgE antibody titers in sera from each recipient of Bcl6 -WT NAT H 2 cells, plus MPT H 2 cells transferred from Bcl6 -TG, Bcl6 -WT, or Bcl6 -KO mice 2 days after the last challenge. All results are representative of four independent experiments with similar outcomes. Data are presented as the mean ± SEM ( n = 5–7). * P < 0.05, ** P < 0.01, comparison between two groups is indicated. AM, alveolar macrophages; BALF, bronchoalveolar lavage fluid; Bcl6, B-cell lymphoma 6; Eos, eosinophils; KJ + , KJ1-26-positive; KO, knockout; Lym, lymphocytes; MPT cell, memory phenotype CD4 + T cell; MPT H 2 cell, MPT cell-derived T H 2 cell; NAT H 2 cell; naïve CD4 + T cell-derived T H 2 cell; Neu, neutrophils; NS, not significant; OVA, ovalbumin; TG, transgenic; WT, wild-type.

Journal: Frontiers in Immunology

Article Title: Allergic T H 2 Response Governed by B-Cell Lymphoma 6 Function in Naturally Occurring Memory Phenotype CD4 + T Cells

doi: 10.3389/fimmu.2018.00750

Figure Lengend Snippet: Role of Bcl6-mediated MPT cell functions in NAT H 2 differentiation in an allergic murine model. [ (A) top] Mixture of purified KJ1-26 − MPT cells ( Bcl6 -WT or Bcl6 -KO) and KJ1-26 + WT naïve CD4 + T cells were transferred into BALB/c nu/nu mice intravenously (day 0). These mice were immunized with alum-conjugated OVA and then intratracheally challenged with OVA. [ (A) bottom] Absolute cell numbers of Neu, Eos, AM, and Lym in BALF, (B) hematoxylin and eosin-stained, formalin-fixed lung sections (magnification: 200×), and (C) T H 2 cytokine levels in the BALF of recipient mice 48 h after the last OVA challenge. (D) Relative Il4, Il5 , and Il13 expression mRNA in splenic KJ1-26 + T cells restimulated with anti-CD3 monoclonal antibodies 5 days after the last challenge. (E) OVA-specific IgE antibody titers in sera from each recipient of Bcl6 -WT NAT H 2 cells, plus MPT H 2 cells transferred from Bcl6 -TG, Bcl6 -WT, or Bcl6 -KO mice 2 days after the last challenge. All results are representative of four independent experiments with similar outcomes. Data are presented as the mean ± SEM ( n = 5–7). * P < 0.05, ** P < 0.01, comparison between two groups is indicated. AM, alveolar macrophages; BALF, bronchoalveolar lavage fluid; Bcl6, B-cell lymphoma 6; Eos, eosinophils; KJ + , KJ1-26-positive; KO, knockout; Lym, lymphocytes; MPT cell, memory phenotype CD4 + T cell; MPT H 2 cell, MPT cell-derived T H 2 cell; NAT H 2 cell; naïve CD4 + T cell-derived T H 2 cell; Neu, neutrophils; NS, not significant; OVA, ovalbumin; TG, transgenic; WT, wild-type.

Article Snippet: IgE anti-OVA Abs were detected using a mouse anti-OVA IgE Antibody Assay Kit (Chondrex, Redmond, WA, USA).

Techniques: Purification, Staining, Expressing, Knock-Out, Derivative Assay, Transgenic Assay

Circulating plasma antibody reactivity to oral commensals identified in pancreatic tumor lesions. Plasma diluent (1/300) from patients with histology verified pancreas tissues: IPMN with low grade dysplasia (LGD-IPMN), IPMN with high grade dysplasia or with invasive cancer (HGD-IPMN + Cancer), or benign tumors/non-IPMN (Control) was tested in duplicates in ELISA plates coated with indicated antigen in (A–F) (bacteria: 5 × 10E7 CFU/ml, peptide 10 μg/mL). The total plasma IgG level is shown in (G) . Internal control Mean OD absorbance values of duplicates are shown. Statistical analysis was performed using the Kolmogorov–Smirnov test, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Journal: Frontiers in Immunology

Article Title: Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy

doi: 10.3389/fimmu.2020.02003

Figure Lengend Snippet: Circulating plasma antibody reactivity to oral commensals identified in pancreatic tumor lesions. Plasma diluent (1/300) from patients with histology verified pancreas tissues: IPMN with low grade dysplasia (LGD-IPMN), IPMN with high grade dysplasia or with invasive cancer (HGD-IPMN + Cancer), or benign tumors/non-IPMN (Control) was tested in duplicates in ELISA plates coated with indicated antigen in (A–F) (bacteria: 5 × 10E7 CFU/ml, peptide 10 μg/mL). The total plasma IgG level is shown in (G) . Internal control Mean OD absorbance values of duplicates are shown. Statistical analysis was performed using the Kolmogorov–Smirnov test, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Article Snippet: Total levels of salivary IgA and plasma IgG antibodies were measured using Human IgA/IgG ELISA Kit (Novus Biologicals, Colorado, United States) according to the manufacturer’s instructions.

Techniques: Clinical Proteomics, Control, Enzyme-linked Immunosorbent Assay, Bacteria

Salivary IgA antibody reactivity to oral commensals quantified by ELISA using saliva diluent (1/16) from indicated patient group. Salivary IgA reactivity to F. nucleatum , the Fap2 mimotope, and S. gordonii (A,B,F) in HG-IPMN/Cancer patients is significantly increased compared to other groups. The differences in antibody levels against bacterial antigens of G. adiacens, S. anginosus , and E. coli (C,D,E) were insignificant between groups. Total plasma IgA level did not differ between the groups (G) . Statistical analysis was performed using the Kolmogorov–Smirnov test, * p < 0.05 and ** p < 0.01.

Journal: Frontiers in Immunology

Article Title: Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy

doi: 10.3389/fimmu.2020.02003

Figure Lengend Snippet: Salivary IgA antibody reactivity to oral commensals quantified by ELISA using saliva diluent (1/16) from indicated patient group. Salivary IgA reactivity to F. nucleatum , the Fap2 mimotope, and S. gordonii (A,B,F) in HG-IPMN/Cancer patients is significantly increased compared to other groups. The differences in antibody levels against bacterial antigens of G. adiacens, S. anginosus , and E. coli (C,D,E) were insignificant between groups. Total plasma IgA level did not differ between the groups (G) . Statistical analysis was performed using the Kolmogorov–Smirnov test, * p < 0.05 and ** p < 0.01.

Article Snippet: Total levels of salivary IgA and plasma IgG antibodies were measured using Human IgA/IgG ELISA Kit (Novus Biologicals, Colorado, United States) according to the manufacturer’s instructions.

Techniques: Enzyme-linked Immunosorbent Assay, Clinical Proteomics

Correlation between circulating plasma (A) or salivary (B) antibody reactivity to F. nucleatum and Fap2 mimotope, or between circulating plasma antibody and salivary antibodies to either of antigen (C,D) . Competitive ELISA (E) with saliva samples with or without antigen pre-absorption as indicated for 2 h, then subjected to Fap2 mimotope ELISA test. Statistical analysis was performed using two-tailed Pearson correlation test and Wilcoxon test for two related samples. ** p < 0.01, ns = not significant.

Journal: Frontiers in Immunology

Article Title: Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy

doi: 10.3389/fimmu.2020.02003

Figure Lengend Snippet: Correlation between circulating plasma (A) or salivary (B) antibody reactivity to F. nucleatum and Fap2 mimotope, or between circulating plasma antibody and salivary antibodies to either of antigen (C,D) . Competitive ELISA (E) with saliva samples with or without antigen pre-absorption as indicated for 2 h, then subjected to Fap2 mimotope ELISA test. Statistical analysis was performed using two-tailed Pearson correlation test and Wilcoxon test for two related samples. ** p < 0.01, ns = not significant.

Article Snippet: Total levels of salivary IgA and plasma IgG antibodies were measured using Human IgA/IgG ELISA Kit (Novus Biologicals, Colorado, United States) according to the manufacturer’s instructions.

Techniques: Clinical Proteomics, Competitive ELISA, Enzyme-linked Immunosorbent Assay, Two Tailed Test